DINOTO, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 297
EU - Europa 246
AS - Asia 127
AF - Africa 18
SA - Sud America 1
Totale 689
Nazione #
US - Stati Uniti d'America 294
CN - Cina 73
RU - Federazione Russa 63
IT - Italia 62
IE - Irlanda 44
SE - Svezia 23
SG - Singapore 23
FR - Francia 19
TG - Togo 18
FI - Finlandia 12
DE - Germania 10
ID - Indonesia 10
HK - Hong Kong 6
IN - India 6
JP - Giappone 4
GB - Regno Unito 3
KR - Corea 3
LU - Lussemburgo 3
CH - Svizzera 2
BE - Belgio 1
BG - Bulgaria 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
JM - Giamaica 1
MX - Messico 1
NL - Olanda 1
TR - Turchia 1
VE - Venezuela 1
VN - Vietnam 1
Totale 689
Città #
Chandler 77
Ashburn 49
Dublin 40
Beijing 27
Lomé 18
Singapore 16
Milan 12
Jakarta 10
New York 8
Helsinki 7
Dallas 6
Hong Kong 6
Kent 6
Lawrence 6
Princeton 6
Verona 6
Florence 5
Lappeenranta 5
Seattle 5
Sindelfingen 5
Washington 5
Bologna 4
Treviso 4
Udine 4
Los Angeles 3
Seoul 3
Southend 3
Boardman 2
Bochum 2
Cursi 2
Delhi 2
Furuichiba 2
Kochi 2
Menlo Park 2
Redmond 2
Rome 2
San Vito dei Normanni 2
Sedico 2
Unterägeri 2
Villafranca di Verona 2
Anconetta 1
Ann Arbor 1
Asolo 1
Brussels 1
Capaccio 1
Distrito Federal 1
Dongguan 1
Fairfield 1
Gurgaon 1
Houston 1
Hyderabad 1
Istanbul 1
Manassas 1
Mexico City 1
Moscow 1
Nishikicho 1
Padova 1
Pasadena 1
Prague 1
Prineville 1
San José 1
Santa Clara 1
Sofia 1
Sopron 1
Tokyo 1
Tolland 1
Weehawken 1
Woodbridge 1
Totale 400
Nome #
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): A Review of Clinical and MRI Features, Diagnosis, and Management 98
Risk of disease relapse following COVID-19 vaccination in patients with AQP4-IgG-positive NMOSD and MOGAD 56
Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients 42
Neuronal intermediate filament paraneoplastic autoimmunity complicating avelumab therapy of Merkel cell carcinoma 35
Serum and cerebrospinal fluid biomarkers in neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein associated disease 34
Is there a correlation between MOGAD and SARS-CoV-2 infection? 34
Neutropenia complicating anti-CD20 treatment in patients with multiple sclerosis: A retrospective case series and a systematic review of reported cases 33
Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders 33
Investigating paraneoplastic aquaporin-4 positive neuromyelitis optica spectrum disorder through a data-driven approach 31
Treatment options in refractory autoimmune encephalitis 29
Neurofilament light chain: a promising diagnostic biomarker for functional motor disorders 29
Autoimmune encephalitis misdiagnosis and mimics 26
More efficient complement activation by Anti-Aquaporin-4 compared with Anti-Myelin Oligodendrocyte Glycoprotein antibodies 25
Cerebellar involvement associated with immune checkpoint inhibitors: a systematic review 22
Increased peripheral inflammatory responses in myelin oligodendrocyte glycoprotein associated disease and aquaporin-4 antibody positive neuromyelitis optica spectrum disorder 22
SARS-CoV-2 antibodies in inflammatory neurological conditions: a multicentre retrospective comparative study 22
Investigating the association between neoplasms and MOG antibody-associated disease 20
Peripheral neuropathy and MOG-IgG: a clinical and neuropathological retrospective study 18
Non-demyelinating disorders mimicking and misdiagnosed as NMOSD, a literature review 18
Serum Biomarker Profiles Discriminate AQP4 Seropositive and Double Seronegative Neuromyelitis Optica Spectrum Disorder 16
Neurologic sequelae of COVID-19 are determined by immunologic imprinting from previous coronaviruses 16
Fatigue in Multiple Sclerosis: a resting-state EEG microstate study 14
Autoimmune movement disorders complicating treatment with immune checkpoint inhibitors 12
A novel cell-based immunofluorescence assay for the detection of autoantibodies to myelin-associated glycoprotein 12
Diagnosing an unusual case of myelitis and diabetes insipidus through skin biopsies 10
HLA-DQB1*05 subtypes and not DRB1*10:01 mediates risk in anti-IgLON5 disease 10
Is there an immunological cross-reactivity of antibodies to the myelin oligodendrocyte glycoprotein and coronaviruses? 8
Clinical Course of Neurologic Adverse Events Associated With Immune Checkpoint Inhibitors: Focus on Chronic Toxicities 3
Totale 728
Categoria #
all - tutte 4.659
article - articoli 4.659
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.318


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202231 0 0 0 0 0 0 0 0 2 13 9 7
2022/2023236 6 18 13 32 18 69 4 15 32 6 13 10
2023/2024294 12 15 23 30 21 48 14 25 12 14 56 24
2024/2025167 48 27 34 58 0 0 0 0 0 0 0 0
Totale 728